EMEA (Europe, Middle East and Africa) Factor VIII Deficiency Treatment Market Report 2017

September 2017 | 116 pages | ID: E9F39AFD4D6EN
QYResearch

Abstracts

In this report, the EMEA Factor VIII Deficiency Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Factor VIII Deficiency Treatment for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Factor VIII Deficiency Treatment market competition by top manufacturers/players, with Factor VIII Deficiency Treatment sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bayer HealthCare
• CSL
• Grifols
• Novo Nordisk
• Pfizer
• Shire
• Alnylam Pharmaceuticals
• Amarna Therapeutics
• Biogen Idec
• BioMarin Pharmaceutical
• Catalyst Biosciences

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Prophylaxis
• On-demand
• Inhibitor

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Factor VIII Deficiency Treatment for each application, including

• Hemophilia A drugs
• Hemophilia A inhibitors treatment
• Von Willebrand disease treatment

Contents

EMEA (Europe, Middle East and Africa) Factor VIII Deficiency Treatment Market Report 2017

1 FACTOR VIII DEFICIENCY TREATMENT OVERVIEW

1.1 Product Overview and Scope of Factor VIII Deficiency Treatment
1.2 Classification of Factor VIII Deficiency Treatment
  1.2.1 EMEA Factor VIII Deficiency Treatment Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Factor VIII Deficiency Treatment Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Prophylaxis
  1.2.4 On-demand
  1.2.5 Inhibitor
1.3 EMEA Factor VIII Deficiency Treatment Market by Application/End Users
  1.3.1 EMEA Factor VIII Deficiency Treatment Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hemophilia A drugs
  1.3.3 Hemophilia A inhibitors treatment
  1.3.4 Von Willebrand disease treatment
1.4 EMEA Factor VIII Deficiency Treatment Market by Region
  1.4.1 EMEA Factor VIII Deficiency Treatment Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Factor VIII Deficiency Treatment (2012-2022)
  1.5.1 EMEA Factor VIII Deficiency Treatment Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Factor VIII Deficiency Treatment Revenue and Growth Rate (2012-2022)

2 EMEA FACTOR VIII DEFICIENCY TREATMENT COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Factor VIII Deficiency Treatment Market Competition by Players/Manufacturers
  2.1.1 EMEA Factor VIII Deficiency Treatment Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Factor VIII Deficiency Treatment Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Factor VIII Deficiency Treatment Sale Price by Players (2012-2017)
2.2 EMEA Factor VIII Deficiency Treatment (Volume and Value) by Type/Product Category
  2.2.1 EMEA Factor VIII Deficiency Treatment Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Factor VIII Deficiency Treatment Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Factor VIII Deficiency Treatment Sale Price by Type (2012-2017)
2.3 EMEA Factor VIII Deficiency Treatment (Volume) by Application
2.4 EMEA Factor VIII Deficiency Treatment (Volume and Value) by Region
  2.4.1 EMEA Factor VIII Deficiency Treatment Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Factor VIII Deficiency Treatment Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Factor VIII Deficiency Treatment Sales Price by Region (2012-2017)

3 EUROPE FACTOR VIII DEFICIENCY TREATMENT (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Factor VIII Deficiency Treatment Sales and Value (2012-2017)
  3.1.1 Europe Factor VIII Deficiency Treatment Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Factor VIII Deficiency Treatment Revenue and Growth Rate (2012-2017)
3.2 Europe Factor VIII Deficiency Treatment Sales and Market Share by Type
3.3 Europe Factor VIII Deficiency Treatment Sales and Market Share by Application
3.4 Europe Factor VIII Deficiency Treatment Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Factor VIII Deficiency Treatment Sales Volume by Countries (2012-2017)
  3.4.2 Europe Factor VIII Deficiency Treatment Revenue by Countries (2012-2017)
  3.4.3 Germany Factor VIII Deficiency Treatment Sales and Growth Rate (2012-2017)
  3.4.4 France Factor VIII Deficiency Treatment Sales and Growth Rate (2012-2017)
  3.4.5 UK Factor VIII Deficiency Treatment Sales and Growth Rate (2012-2017)
  3.4.6 Russia Factor VIII Deficiency Treatment Sales and Growth Rate (2012-2017)
  3.4.7 Italy Factor VIII Deficiency Treatment Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Factor VIII Deficiency Treatment Sales and Growth Rate (2012-2017)

4 MIDDLE EAST FACTOR VIII DEFICIENCY TREATMENT (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Factor VIII Deficiency Treatment Sales and Value (2012-2017)
  4.1.1 Middle East Factor VIII Deficiency Treatment Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Factor VIII Deficiency Treatment Revenue and Growth Rate (2012-2017)
4.2 Middle East Factor VIII Deficiency Treatment Sales and Market Share by Type
4.3 Middle East Factor VIII Deficiency Treatment Sales and Market Share by Application
4.4 Middle East Factor VIII Deficiency Treatment Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Factor VIII Deficiency Treatment Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Factor VIII Deficiency Treatment Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Factor VIII Deficiency Treatment Sales and Growth Rate (2012-2017)
  4.4.4 Israel Factor VIII Deficiency Treatment Sales and Growth Rate (2012-2017)
  4.4.5 UAE Factor VIII Deficiency Treatment Sales and Growth Rate (2012-2017)
  4.4.6 Iran Factor VIII Deficiency Treatment Sales and Growth Rate (2012-2017)

5 AFRICA FACTOR VIII DEFICIENCY TREATMENT (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Factor VIII Deficiency Treatment Sales and Value (2012-2017)
  5.1.1 Africa Factor VIII Deficiency Treatment Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Factor VIII Deficiency Treatment Revenue and Growth Rate (2012-2017)
5.2 Africa Factor VIII Deficiency Treatment Sales and Market Share by Type
5.3 Africa Factor VIII Deficiency Treatment Sales and Market Share by Application
5.4 Africa Factor VIII Deficiency Treatment Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Factor VIII Deficiency Treatment Sales Volume by Countries (2012-2017)
  5.4.2 Africa Factor VIII Deficiency Treatment Revenue by Countries (2012-2017)
  5.4.3 South Africa Factor VIII Deficiency Treatment Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Factor VIII Deficiency Treatment Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Factor VIII Deficiency Treatment Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Factor VIII Deficiency Treatment Sales and Growth Rate (2012-2017)

6 EMEA FACTOR VIII DEFICIENCY TREATMENT MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Bayer HealthCare
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Factor VIII Deficiency Treatment Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer HealthCare Factor VIII Deficiency Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 CSL
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Factor VIII Deficiency Treatment Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 CSL Factor VIII Deficiency Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Grifols
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Factor VIII Deficiency Treatment Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Grifols Factor VIII Deficiency Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Novo Nordisk
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Factor VIII Deficiency Treatment Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Novo Nordisk Factor VIII Deficiency Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pfizer
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Factor VIII Deficiency Treatment Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pfizer Factor VIII Deficiency Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Shire
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Factor VIII Deficiency Treatment Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Shire Factor VIII Deficiency Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Alnylam Pharmaceuticals
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Factor VIII Deficiency Treatment Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Alnylam Pharmaceuticals Factor VIII Deficiency Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Amarna Therapeutics
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Factor VIII Deficiency Treatment Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Amarna Therapeutics Factor VIII Deficiency Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Biogen Idec
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Factor VIII Deficiency Treatment Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Biogen Idec Factor VIII Deficiency Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 BioMarin Pharmaceutical
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Factor VIII Deficiency Treatment Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Catalyst Biosciences

7 FACTOR VIII DEFICIENCY TREATMENT MANUFACTURING COST ANALYSIS

7.1 Factor VIII Deficiency Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Factor VIII Deficiency Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Factor VIII Deficiency Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Factor VIII Deficiency Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA FACTOR VIII DEFICIENCY TREATMENT MARKET FORECAST (2017-2022)

11.1 EMEA Factor VIII Deficiency Treatment Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Factor VIII Deficiency Treatment Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Factor VIII Deficiency Treatment Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Factor VIII Deficiency Treatment Price and Trend Forecast (2017-2022)
11.2 EMEA Factor VIII Deficiency Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Factor VIII Deficiency Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Factor VIII Deficiency Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Factor VIII Deficiency Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Factor VIII Deficiency Treatment Sales Forecast by Type (2017-2022)
11.7 EMEA Factor VIII Deficiency Treatment Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Factor VIII Deficiency Treatment
Figure EMEA Factor VIII Deficiency Treatment Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Factor VIII Deficiency Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Prophylaxis Product Picture
Figure On-demand Product Picture
Figure Inhibitor Product Picture
Figure EMEA Factor VIII Deficiency Treatment Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Factor VIII Deficiency Treatment by Application in 2016
Figure Hemophilia A drugs Examples
Figure Hemophilia A inhibitors treatment Examples
Figure Von Willebrand disease treatment Examples
Figure EMEA Factor VIII Deficiency Treatment Market Size (Million USD) by Region (2012-2022)
Figure Europe Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Factor VIII Deficiency Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Factor VIII Deficiency Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Africa Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Factor VIII Deficiency Treatment Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Factor VIII Deficiency Treatment Sales Volume and Growth Rate (2012-2022)
Figure EMEA Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Factor VIII Deficiency Treatment Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Factor VIII Deficiency Treatment Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Factor VIII Deficiency Treatment Sales Share by Players (2012-2017)
Figure 2016 Factor VIII Deficiency Treatment Sales Share by Players
Figure 2017 Factor VIII Deficiency Treatment Sales Share by Players
Figure EMEA Factor VIII Deficiency Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Factor VIII Deficiency Treatment Revenue (Million USD) by Players (2012-2017)
Table EMEA Factor VIII Deficiency Treatment Revenue Share by Players (2012-2017)
Table 2016 EMEA Factor VIII Deficiency Treatment Revenue Share by Players
Table 2017 EMEA Factor VIII Deficiency Treatment Revenue Share by Players
Table EMEA Factor VIII Deficiency Treatment Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Factor VIII Deficiency Treatment Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Factor VIII Deficiency Treatment Sales Share by Type (2012-2017)
Figure Sales Market Share of Factor VIII Deficiency Treatment by Type (2012-2017)
Figure EMEA Factor VIII Deficiency Treatment Sales Market Share by Type (2012-2017)
Table EMEA Factor VIII Deficiency Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Factor VIII Deficiency Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Factor VIII Deficiency Treatment by Type in 2016
Table EMEA Factor VIII Deficiency Treatment Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Factor VIII Deficiency Treatment Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Factor VIII Deficiency Treatment Sales Share by Application (2012-2017)
Figure Sales Market Share of Factor VIII Deficiency Treatment by Application (2012-2017)
Figure EMEA Factor VIII Deficiency Treatment Sales Market Share by Application in 2016
Table EMEA Factor VIII Deficiency Treatment Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Factor VIII Deficiency Treatment Sales Share by Region (2012-2017)
Figure Sales Market Share of Factor VIII Deficiency Treatment by Region (2012-2017)
Figure EMEA Factor VIII Deficiency Treatment Sales Market Share in 2016
Table EMEA Factor VIII Deficiency Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Factor VIII Deficiency Treatment Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Factor VIII Deficiency Treatment by Region (2012-2017)
Figure EMEA Factor VIII Deficiency Treatment Revenue Market Share Regions in 2016
Table EMEA Factor VIII Deficiency Treatment Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Factor VIII Deficiency Treatment Revenue and Growth Rate (2012-2017)
Table Europe Factor VIII Deficiency Treatment Sales (K Units) by Type (2012-2017)
Table Europe Factor VIII Deficiency Treatment Market Share by Type (2012-2017)
Figure Europe Factor VIII Deficiency Treatment Market Share by Type in 2016
Table Europe Factor VIII Deficiency Treatment Sales (K Units) by Application (2012-2017)
Table Europe Factor VIII Deficiency Treatment Market Share by Application (2012-2017)
Figure Europe Factor VIII Deficiency Treatment Market Share by Application in 2016
Table Europe Factor VIII Deficiency Treatment Sales (K Units) by Countries (2012-2017)
Table Europe Factor VIII Deficiency Treatment Sales Market Share by Countries (2012-2017)
Figure Europe Factor VIII Deficiency Treatment Sales Market Share by Countries (2012-2017)
Figure Europe Factor VIII Deficiency Treatment Sales Market Share by Countries in 2016
Table Europe Factor VIII Deficiency Treatment Revenue (Million USD) by Countries (2012-2017)
Table Europe Factor VIII Deficiency Treatment Revenue Market Share by Countries (2012-2017)
Figure Europe Factor VIII Deficiency Treatment Revenue Market Share by Countries (2012-2017)
Figure Europe Factor VIII Deficiency Treatment Revenue Market Share by Countries in 2016
Figure Germany Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure France Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure UK Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Factor VIII Deficiency Treatment Sales (K Units) by Type (2012-2017)
Table Middle East Factor VIII Deficiency Treatment Market Share by Type (2012-2017)
Figure Middle East Factor VIII Deficiency Treatment Market Share by Type (2012-2017)
Table Middle East Factor VIII Deficiency Treatment Sales (K Units) by Applications (2012-2017)
Table Middle East Factor VIII Deficiency Treatment Market Share by Applications (2012-2017)
Figure Middle East Factor VIII Deficiency Treatment Sales Market Share by Application in 2016
Table Middle East Factor VIII Deficiency Treatment Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Factor VIII Deficiency Treatment Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Factor VIII Deficiency Treatment Sales Volume Market Share by Countries in 2016
Table Middle East Factor VIII Deficiency Treatment Revenue (Million USD) by Countries (2012-2017)
Table Middle East Factor VIII Deficiency Treatment Revenue Market Share by Countries (2012-2017)
Figure Middle East Factor VIII Deficiency Treatment Revenue Market Share by Countries (2012-2017)
Figure Middle East Factor VIII Deficiency Treatment Revenue Market Share by Countries in 2016
Figure Saudi Arabia Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Factor VIII Deficiency Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Factor VIII Deficiency Treatment Sales (K Units) by Type (2012-2017)
Table Africa Factor VIII Deficiency Treatment Sales Market Share by Type (2012-2017)
Figure Africa Factor VIII Deficiency Treatment Sales Market Share by Type (2012-2017)
Figure Africa Factor VIII Deficiency Treatment Sales Market Share by Type in 2016
Table Africa Factor VIII Deficiency Treatment Sales (K Units) by Application (2012-2017)
Table Africa Factor VIII Deficiency Treatment Sales Market Share by Application (2012-2017)
Figure Africa Factor VIII Deficiency Treatment Sales Market Share by Application (2012-2017)
Table Africa Factor VIII Deficiency Treatment Sales Volume (K Units) by Countries (2012-2017)
Table Africa Factor VIII Deficiency Treatment Sales Market Share by Countries (2012-2017)
Figure Africa Factor VIII Deficiency Treatment Sales Market Share by Countries (2012-2017)
Figure Africa Factor VIII Deficiency Treatment Sales Market Share by Countries in 2016
Table Africa Factor VIII Deficiency Treatment Revenue (Million USD) by Countries (2012-2017)
Table Africa Factor VIII Deficiency Treatment Revenue Market Share by Countries (2012-2017)
Figure Africa Factor VIII Deficiency Treatment Revenue Market Share by Countries (2012-2017)
Figure Africa Factor VIII Deficiency Treatment Revenue Market Share by Countries in 2016
Figure South Africa Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Table Bayer HealthCare Factor VIII Deficiency Treatment Basic Information List
Table Bayer HealthCare Factor VIII Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer HealthCare Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer HealthCare Factor VIII Deficiency Treatment Sales Market Share in EMEA (2012-2017)
Figure Bayer HealthCare Factor VIII Deficiency Treatment Revenue Market Share in EMEA (2012-2017)
Table CSL Factor VIII Deficiency Treatment Basic Information List
Table CSL Factor VIII Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CSL Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure CSL Factor VIII Deficiency Treatment Sales Market Share in EMEA (2012-2017)
Figure CSL Factor VIII Deficiency Treatment Revenue Market Share in EMEA (2012-2017)
Table Grifols Factor VIII Deficiency Treatment Basic Information List
Table Grifols Factor VIII Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Grifols Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Grifols Factor VIII Deficiency Treatment Sales Market Share in EMEA (2012-2017)
Figure Grifols Factor VIII Deficiency Treatment Revenue Market Share in EMEA (2012-2017)
Table Novo Nordisk Factor VIII Deficiency Treatment Basic Information List
Table Novo Nordisk Factor VIII Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Novo Nordisk Factor VIII Deficiency Treatment Sales Market Share in EMEA (2012-2017)
Figure Novo Nordisk Factor VIII Deficiency Treatment Revenue Market Share in EMEA (2012-2017)
Table Pfizer Factor VIII Deficiency Treatment Basic Information List
Table Pfizer Factor VIII Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Factor VIII Deficiency Treatment Sales Market Share in EMEA (2012-2017)
Figure Pfizer Factor VIII Deficiency Treatment Revenue Market Share in EMEA (2012-2017)
Table Shire Factor VIII Deficiency Treatment Basic Information List
Table Shire Factor VIII Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shire Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Shire Factor VIII Deficiency Treatment Sales Market Share in EMEA (2012-2017)
Figure Shire Factor VIII Deficiency Treatment Revenue Market Share in EMEA (2012-2017)
Table Alnylam Pharmaceuticals Factor VIII Deficiency Treatment Basic Information List
Table Alnylam Pharmaceuticals Factor VIII Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Alnylam Pharmaceuticals Factor VIII Deficiency Treatment Sales Market Share in EMEA (2012-2017)
Figure Alnylam Pharmaceuticals Factor VIII Deficiency Treatment Revenue Market Share in EMEA (2012-2017)
Table Amarna Therapeutics Factor VIII Deficiency Treatment Basic Information List
Table Amarna Therapeutics Factor VIII Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amarna Therapeutics Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Amarna Therapeutics Factor VIII Deficiency Treatment Sales Market Share in EMEA (2012-2017)
Figure Amarna Therapeutics Factor VIII Deficiency Treatment Revenue Market Share in EMEA (2012-2017)
Table Biogen Idec Factor VIII Deficiency Treatment Basic Information List
Table Biogen Idec Factor VIII Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biogen Idec Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Biogen Idec Factor VIII Deficiency Treatment Sales Market Share in EMEA (2012-2017)
Figure Biogen Idec Factor VIII Deficiency Treatment Revenue Market Share in EMEA (2012-2017)
Table BioMarin Pharmaceutical Factor VIII Deficiency Treatment Basic Information List
Table BioMarin Pharmaceutical Factor VIII Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BioMarin Pharmaceutical Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure BioMarin Pharmaceutical Factor VIII Deficiency Treatment Sales Market Share in EMEA (2012-2017)
Figure BioMarin Pharmaceutical Factor VIII Deficiency Treatment Revenue Market Share in EMEA (2012-2017)
Table Catalyst Biosciences Factor VIII Deficiency Treatment Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Factor VIII Deficiency Treatment
Figure Manufacturing Process Analysis of Factor VIII Deficiency Treatment
Figure Factor VIII Deficiency Treatment Industrial Chain Analysis
Table Raw Materials Sources of Factor VIII Deficiency Treatment Major Manufacturers in 2016
Table Major Buyers of Factor VIII Deficiency Treatment
Table Distributors/Traders List
Figure EMEA Factor VIII Deficiency Treatment Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Factor VIII Deficiency Treatment Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Factor VIII Deficiency Treatment Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Factor VIII Deficiency Treatment Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Factor VIII Deficiency Treatment Sales Market Share Forecast by Region (2017-2022)
Table EMEA Factor VIII Deficiency Treatment Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Factor VIII Deficiency Treatment Revenue Market Share Forecast by Region (2017-2022)
Table Europe Factor VIII Deficiency Treatment Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Factor VIII Deficiency Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Europe Factor VIII Deficiency Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Factor VIII Deficiency Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Factor VIII Deficiency Treatment Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Factor VIII Deficiency Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Factor VIII Deficiency Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Factor VIII Deficiency Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Factor VIII Deficiency Treatment Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Factor VIII Deficiency Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Africa Factor VIII Deficiency Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Factor VIII Deficiency Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Factor VIII Deficiency Treatment Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Factor VIII Deficiency Treatment Sales Market Share Forecast by Type (2017-2022)
Table EMEA Factor VIII Deficiency Treatment Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Factor VIII Deficiency Treatment Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources